US Stock MarketDetailed Quotes

GMED Globus Medical

Watchlist
  • 72.550
  • -1.110-1.51%
Close Mar 28 16:00 ET
  • 72.550
  • 0.0000.00%
Post 18:34 ET
9.98BMarket Cap96.73P/E (TTM)

Globus Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
60.62%2.52B
6.61%657.29M
63.10%625.71M
115.93%629.69M
119.26%606.67M
53.34%1.57B
124.60%616.53M
50.95%383.64M
10.61%291.62M
20.01%276.69M
Operating revenue
60.62%2.52B
6.61%657.29M
63.10%625.71M
115.93%629.69M
119.26%606.67M
53.34%1.57B
124.60%616.53M
50.95%383.64M
10.61%291.62M
20.01%276.69M
Cost of revenue
88.90%1.04B
-0.77%263.44M
99.80%270.52M
240.04%260.04M
240.96%241.49M
107.86%548.17M
276.09%265.49M
106.71%135.39M
11.69%76.47M
19.70%70.83M
Gross profit
45.43%1.48B
12.19%393.86M
43.08%355.19M
71.82%369.65M
77.39%365.18M
34.41%1.02B
72.16%351.05M
31.59%248.25M
10.23%215.14M
20.12%205.86M
Operating expense
54.46%1.26B
-2.55%316.8M
53.64%306.19M
109.32%305.53M
126.64%335.65M
56.53%818.45M
128.80%325.09M
53.78%199.3M
13.58%145.96M
20.73%148.1M
Selling and administrative expenses
52.48%981.05M
3.58%253.48M
54.12%240.74M
98.32%238.12M
103.17%248.71M
48.90%643.41M
107.26%244.72M
46.57%156.21M
12.51%120.07M
21.51%122.42M
Research and development costs
32.05%163.75M
-36.06%33.41M
20.63%35.38M
76.60%37.7M
171.64%57.27M
69.84%124.01M
167.86%52.25M
56.83%29.33M
22.72%21.35M
21.08%21.08M
Depreciation amortization depletion
133.92%119.37M
6.36%29.91M
118.56%30.08M
553.38%29.71M
544.99%29.68M
187.75%51.03M
524.12%28.12M
218.25%13.76M
3.51%4.55M
1.97%4.6M
-Depreciation and amortization
133.92%119.37M
6.36%29.91M
118.56%30.08M
553.38%29.71M
544.99%29.68M
187.75%51.03M
524.12%28.12M
218.25%13.76M
3.51%4.55M
1.97%4.6M
Operating profit
8.84%219.7M
196.89%77.06M
0.09%49M
-7.31%64.13M
-48.89%29.53M
-14.56%201.85M
-58.02%25.95M
-17.10%48.95M
3.76%69.18M
18.59%57.76M
Net non-operating interest income expense
-120.81%-4.19M
131.58%815K
-109.79%-775K
-128.15%-2.34M
-129.15%-1.89M
41.43%20.13M
-148.56%-2.58M
103.13%7.92M
234.98%8.29M
155.49%6.5M
Total other finance cost
120.81%4.19M
-131.58%-815K
109.79%775K
128.15%2.34M
129.15%1.89M
-41.43%-20.13M
148.56%2.58M
-103.13%-7.92M
-234.98%-8.29M
-155.49%-6.5M
Other net income (expense)
-67.51%-94.79M
-3,382.11%-53.2M
116.22%8.81M
-407.65%-14.21M
-3,275.84%-36.19M
-658.03%-56.59M
132.30%1.62M
-3,561.59%-54.34M
-301.08%-2.8M
54.48%-1.07M
Gain on sale of security
-403.56%-43.29M
-288.32%-37.49M
293.43%10.28M
-28.28%-703K
-7,350.47%-15.37M
1,497.94%14.26M
640.63%19.91M
-140.45%-5.31M
50.50%-548K
154.22%212K
Special income (charges)
21.83%-53.71M
-6.00%-16.78M
98.15%-898K
-388.81%-14.5M
-1,481.78%-21.53M
-727.81%-68.71M
-103.20%-15.83M
-7,546.17%-48.55M
-368.75%-2.97M
39.91%-1.36M
-Less:Restructuring and merger&acquisition
-21.79%53.4M
9.72%17.1M
-96.55%1.57M
130.73%13.17M
1,484.06%21.56M
1,045.73%68.27M
99.99%15.58M
7,097.70%45.63M
616.94%5.71M
1,890.79%1.36M
-Less:Other special charges
-27.65%314K
-225.60%-314K
-123.12%-676K
148.72%1.34M
---31K
-81.46%434K
--250K
--2.92M
---2.74M
----
Other non- operating income (expenses)
203.13%2.21M
143.49%1.07M
-20.00%-570K
39.25%997K
822.08%710K
-215.26%-2.14M
-2,989.41%-2.46M
-741.89%-475K
-48.67%716K
-74.42%77K
Income before tax
-27.01%120.72M
-1.31%24.67M
2,149.78%57.03M
-36.28%47.58M
-113.54%-8.56M
-31.94%165.39M
-59.76%24.99M
-95.88%2.54M
5.86%74.67M
29.23%63.19M
Income tax
-58.28%17.74M
-118.45%-1.84M
238.06%5.2M
-6.73%15.82M
-110.25%-1.44M
-19.55%42.52M
-17.35%9.96M
-89.05%1.54M
6.34%16.96M
30.02%14.06M
Net income
-16.19%102.98M
76.30%26.51M
5,093.99%51.84M
-44.97%31.76M
-114.49%-7.12M
-35.39%122.87M
-69.97%15.03M
-97.90%998K
5.72%57.71M
29.00%49.13M
Net income continuous Operations
-16.19%102.98M
76.30%26.51M
5,093.99%51.84M
-44.97%31.76M
-114.49%-7.12M
-35.39%122.87M
-69.97%15.03M
-97.90%998K
5.72%57.71M
29.00%49.13M
Minority interest income
Net income attributable to the parent company
-16.19%102.98M
76.30%26.51M
5,093.99%51.84M
-44.97%31.76M
-114.49%-7.12M
-35.39%122.87M
-69.97%15.03M
-97.90%998K
5.72%57.71M
29.00%49.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.19%102.98M
76.30%26.51M
5,093.99%51.84M
-44.97%31.76M
-114.49%-7.12M
-35.39%122.87M
-69.97%15.03M
-97.90%998K
5.72%57.71M
29.00%49.13M
Basic earnings per share
-30.28%0.76
72.73%0.19
3,700.00%0.38
-59.65%0.23
-110.20%-0.05
-42.33%1.09
-78.00%0.11
-97.92%0.01
5.56%0.57
32.43%0.49
Diluted earnings per share
-29.91%0.75
72.73%0.19
3,700.00%0.38
-59.65%0.23
-110.42%-0.05
-42.16%1.07
-77.55%0.11
-97.87%0.01
7.55%0.57
29.73%0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 60.62%2.52B6.61%657.29M63.10%625.71M115.93%629.69M119.26%606.67M53.34%1.57B124.60%616.53M50.95%383.64M10.61%291.62M20.01%276.69M
Operating revenue 60.62%2.52B6.61%657.29M63.10%625.71M115.93%629.69M119.26%606.67M53.34%1.57B124.60%616.53M50.95%383.64M10.61%291.62M20.01%276.69M
Cost of revenue 88.90%1.04B-0.77%263.44M99.80%270.52M240.04%260.04M240.96%241.49M107.86%548.17M276.09%265.49M106.71%135.39M11.69%76.47M19.70%70.83M
Gross profit 45.43%1.48B12.19%393.86M43.08%355.19M71.82%369.65M77.39%365.18M34.41%1.02B72.16%351.05M31.59%248.25M10.23%215.14M20.12%205.86M
Operating expense 54.46%1.26B-2.55%316.8M53.64%306.19M109.32%305.53M126.64%335.65M56.53%818.45M128.80%325.09M53.78%199.3M13.58%145.96M20.73%148.1M
Selling and administrative expenses 52.48%981.05M3.58%253.48M54.12%240.74M98.32%238.12M103.17%248.71M48.90%643.41M107.26%244.72M46.57%156.21M12.51%120.07M21.51%122.42M
Research and development costs 32.05%163.75M-36.06%33.41M20.63%35.38M76.60%37.7M171.64%57.27M69.84%124.01M167.86%52.25M56.83%29.33M22.72%21.35M21.08%21.08M
Depreciation amortization depletion 133.92%119.37M6.36%29.91M118.56%30.08M553.38%29.71M544.99%29.68M187.75%51.03M524.12%28.12M218.25%13.76M3.51%4.55M1.97%4.6M
-Depreciation and amortization 133.92%119.37M6.36%29.91M118.56%30.08M553.38%29.71M544.99%29.68M187.75%51.03M524.12%28.12M218.25%13.76M3.51%4.55M1.97%4.6M
Operating profit 8.84%219.7M196.89%77.06M0.09%49M-7.31%64.13M-48.89%29.53M-14.56%201.85M-58.02%25.95M-17.10%48.95M3.76%69.18M18.59%57.76M
Net non-operating interest income expense -120.81%-4.19M131.58%815K-109.79%-775K-128.15%-2.34M-129.15%-1.89M41.43%20.13M-148.56%-2.58M103.13%7.92M234.98%8.29M155.49%6.5M
Total other finance cost 120.81%4.19M-131.58%-815K109.79%775K128.15%2.34M129.15%1.89M-41.43%-20.13M148.56%2.58M-103.13%-7.92M-234.98%-8.29M-155.49%-6.5M
Other net income (expense) -67.51%-94.79M-3,382.11%-53.2M116.22%8.81M-407.65%-14.21M-3,275.84%-36.19M-658.03%-56.59M132.30%1.62M-3,561.59%-54.34M-301.08%-2.8M54.48%-1.07M
Gain on sale of security -403.56%-43.29M-288.32%-37.49M293.43%10.28M-28.28%-703K-7,350.47%-15.37M1,497.94%14.26M640.63%19.91M-140.45%-5.31M50.50%-548K154.22%212K
Special income (charges) 21.83%-53.71M-6.00%-16.78M98.15%-898K-388.81%-14.5M-1,481.78%-21.53M-727.81%-68.71M-103.20%-15.83M-7,546.17%-48.55M-368.75%-2.97M39.91%-1.36M
-Less:Restructuring and merger&acquisition -21.79%53.4M9.72%17.1M-96.55%1.57M130.73%13.17M1,484.06%21.56M1,045.73%68.27M99.99%15.58M7,097.70%45.63M616.94%5.71M1,890.79%1.36M
-Less:Other special charges -27.65%314K-225.60%-314K-123.12%-676K148.72%1.34M---31K-81.46%434K--250K--2.92M---2.74M----
Other non- operating income (expenses) 203.13%2.21M143.49%1.07M-20.00%-570K39.25%997K822.08%710K-215.26%-2.14M-2,989.41%-2.46M-741.89%-475K-48.67%716K-74.42%77K
Income before tax -27.01%120.72M-1.31%24.67M2,149.78%57.03M-36.28%47.58M-113.54%-8.56M-31.94%165.39M-59.76%24.99M-95.88%2.54M5.86%74.67M29.23%63.19M
Income tax -58.28%17.74M-118.45%-1.84M238.06%5.2M-6.73%15.82M-110.25%-1.44M-19.55%42.52M-17.35%9.96M-89.05%1.54M6.34%16.96M30.02%14.06M
Net income -16.19%102.98M76.30%26.51M5,093.99%51.84M-44.97%31.76M-114.49%-7.12M-35.39%122.87M-69.97%15.03M-97.90%998K5.72%57.71M29.00%49.13M
Net income continuous Operations -16.19%102.98M76.30%26.51M5,093.99%51.84M-44.97%31.76M-114.49%-7.12M-35.39%122.87M-69.97%15.03M-97.90%998K5.72%57.71M29.00%49.13M
Minority interest income
Net income attributable to the parent company -16.19%102.98M76.30%26.51M5,093.99%51.84M-44.97%31.76M-114.49%-7.12M-35.39%122.87M-69.97%15.03M-97.90%998K5.72%57.71M29.00%49.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.19%102.98M76.30%26.51M5,093.99%51.84M-44.97%31.76M-114.49%-7.12M-35.39%122.87M-69.97%15.03M-97.90%998K5.72%57.71M29.00%49.13M
Basic earnings per share -30.28%0.7672.73%0.193,700.00%0.38-59.65%0.23-110.20%-0.05-42.33%1.09-78.00%0.11-97.92%0.015.56%0.5732.43%0.49
Diluted earnings per share -29.91%0.7572.73%0.193,700.00%0.38-59.65%0.23-110.42%-0.05-42.16%1.07-77.55%0.11-97.87%0.017.55%0.5729.73%0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.